HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabotropic glutamate receptor subtype 7 in the dorsal striatum oppositely modulates pain in sham and neuropathic rats.

Abstract
The study investigated the role of the metabotropic glutamate receptor subtype 7 (mGluR7) in pain signalling in the dorsal striatum of sham and neuropathic rats. Supraspinal circuitries involved in the dorsal striatum control of pain were also explored. In the sham rats, microinjection of N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082), a selective mGluR7 positive allosteric modulator, into the dorsal striatum, facilitated pain, increased the activity of the ON cells and inhibited the activity of the OFF cells in the rostral ventromedial medulla, and decreased glutamate levels in the dorsal striatum. Conversely, AMN082 inhibited pain and the activity of the ON cells while increased the activity of the OFF cells in rats with spared nerve injury (SNI) of the sciatic nerve. AMN082 also decreased glutamate levels in the dorsal striatum of SNI rats. The effect of AMN082 on mechanical allodynia and glutamate release was blocked by 6-(2,4-dimethylphenyl)-2-ethyl-6,7-dihydro-4(5H)-benzoxazolone (ADX71743), a selective mGluR7 negative allosteric modulator. Moreover, in the sham rats, AMN082 increased the activity of total nociceptive convergent neurons in the dorsal reticular nucleus while in the SNI rats, such activity was decreased. The administration of lidocaine into the subthalamic nucleus abolished the effect of AMN082 on the total nociceptive convergent neurons in the sham rats but not in the SNI rats. Thus, the dual effect of mGluR7 in facilitating or inhibiting pain responses may be due to the recruitment of different pathways of the basal ganglia, the indirect or direct pathway, in physiological or pathological conditions, respectively.
AuthorsIda Marabese, Serena Boccella, Monica Iannotta, Livio Luongo, Vito de Novellis, Francesca Guida, Nicola Serra, Antonio Farina, Sabatino Maione, Enza Palazzo
JournalNeuropharmacology (Neuropharmacology) Vol. 135 Pg. 86-99 (06 2018) ISSN: 1873-7064 [Electronic] England
PMID29505788 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Chemical References
  • ADX71743
  • Benzhydryl Compounds
  • Benzoxazoles
  • N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride
  • Neuroprotective Agents
  • Receptors, Metabotropic Glutamate
  • metabotropic glutamate receptor 7
  • Glutamic Acid
  • Lidocaine
Topics
  • Animals
  • Benzhydryl Compounds (antagonists & inhibitors, pharmacology, therapeutic use)
  • Benzoxazoles (pharmacology)
  • Corpus Striatum (metabolism)
  • Glutamic Acid (metabolism)
  • Hyperalgesia (drug therapy)
  • Lidocaine (pharmacology)
  • Male
  • Medulla Oblongata (drug effects)
  • Microinjections
  • Neuralgia (physiopathology)
  • Neurons (drug effects)
  • Neuroprotective Agents (pharmacology)
  • Pain (physiopathology)
  • Rats
  • Receptors, Metabotropic Glutamate (agonists, physiology)
  • Reticular Formation (physiology)
  • Sciatic Nerve (injuries)
  • Subthalamic Nucleus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: